Table 3.
Model Adjustment Factors* | OR (95%CI) for WMH change ≥1 grade | ||
---|---|---|---|
BP < 140/90 | BP ≥ 140/90 | ||
N=1168 | N=678 | ||
A | Demographics | 0.74 (0.48–1.15) | 1.69 (1.03–2.82) |
B | A + Baseline WMH grade and time between scans | 0.75 (0.48–1.16) | 1.74 (1.04–1.92) |
C | B + Vascular risk factors and comorbidities | 0.77 (0.49–1.21) | 1.83 (1.07–3.15) |
D | B + Measures of vascular disease | 0.70 (0.44–1.11) | 1.84 (1.08–3.06) |
E | B + History of stroke | 0.74 (0.48–1.14) | 1.70 (1.02–3.29) |
F | B + Cystatin C | 0.72 (0.46–1.14) | 1.60 (1.01–2.70) |
G | B + Inflammation | 0.74 (0.48–1.17) | 1.59 (1.01–2.83) |
H | B + Medications | 0.73 (0.47–1.13) | 1.69 (1.01–2.82) |
I | B + Incident stroke | 0.76 (0.49–1.18) | 1.68 (1.02–2.83) |
Fully adjusted | 0.68 (0.41–1.10) | 1.79 (1.03–2.98) |
Models are adjusted for the following variables:
A. Age, gender and race.
B. Model A + baseline WMH grade and time between the scans.
C. Model B + body mass index, diabetes, smoking status (current/past Vs. never), LDL, HDL, dizziness, factor VII and prevalent cardiovascular diseases.
D. Model B + ankle-arm index, left ventricular hypertrophy by ECG
E. Model B + history of stroke
F. Model B + Cystatin C
G. Model B + inflammation (at least two of: low albumin, high CRP, white blood cells, fibrinogen)
H. Model B + lowering-lipid medications, antihypertensive medications and aspirin use.
I. Model B + strokes between the two MRI scans.
Fully adjusted: adjusted for all the above mentioned covariates.